Diagnosing thyrotoxic periodic paralysis in the ED

Yuh Feng Lin, Chia Chao Wu, Dee Pei, Shi Jye Chu, Shih Hua Lin

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Thyrotoxic periodic paralysis (TPP) and sporadic periodic paralysis (SPP) are the most common causes of hypokalemic periodic paralysis (HPP) in EDs in Asia. Their neuromuscular presentations are almost indistinguishable. We conducted this study to identify clinical clues that can help EPs distinguish between TPP and SPP. Thirty-four patients presenting to the ED with HPP were enrolled during a 3-year period. They did not have known hyperthyroidism before the attack and no family history of paralysis. They all had low K+ excretion rates. Vital signs and blood biochemistry, including acid-base and electrolytes, were measured. TPP was subsequently established by thyroid function tests. Twenty patients had TPP and 14 patients had SPP. There was no significant difference in age and sex distribution between them. Systolic (SBP) but not diastolic blood pressure (SBP 146 ± 4 vs 128 ± 4 mm Hg, P <0.001) and heart rate (106 ± 3 vs 73 ± 3 beats/min, P <0.001) were significantly higher in those experiencing TPP than SPP. Among the biochemical factors, only plasma phosphate concentration (2.2 ± 0.2 vs 3.2 ± 0.2 mg/dL, P <0.001) was significantly lower in those experiencing TPP than SPP. Systolic hypertension, tachycardia, and hypophosphatemia are clinical clues favoring the diagnosis of TPP.

Original languageEnglish
Pages (from-to)339-342
Number of pages4
JournalAmerican Journal of Emergency Medicine
Volume21
Issue number4
DOIs
Publication statusPublished - Jul 2003
Externally publishedYes

Fingerprint

Paralysis
Hypokalemic Periodic Paralysis
Blood Pressure
Hypophosphatemia
Thyroid Function Tests
Sex Distribution
Vital Signs
Age Distribution
Hyperthyroidism
Tachycardia
Biochemistry
Electrolytes
Heart Rate
Phosphates
Hypertension

Keywords

  • Beta-blockers
  • Blood pressure
  • Heart rate
  • Hyperthyroidism
  • Hypokalemia
  • Hypophosphatemia
  • Paralysis

ASJC Scopus subject areas

  • Emergency Medicine

Cite this

Diagnosing thyrotoxic periodic paralysis in the ED. / Lin, Yuh Feng; Wu, Chia Chao; Pei, Dee; Chu, Shi Jye; Lin, Shih Hua.

In: American Journal of Emergency Medicine, Vol. 21, No. 4, 07.2003, p. 339-342.

Research output: Contribution to journalArticle

Lin, Yuh Feng ; Wu, Chia Chao ; Pei, Dee ; Chu, Shi Jye ; Lin, Shih Hua. / Diagnosing thyrotoxic periodic paralysis in the ED. In: American Journal of Emergency Medicine. 2003 ; Vol. 21, No. 4. pp. 339-342.
@article{fa6fe2d6e6e24df1bd9ea5755c33e4a5,
title = "Diagnosing thyrotoxic periodic paralysis in the ED",
abstract = "Thyrotoxic periodic paralysis (TPP) and sporadic periodic paralysis (SPP) are the most common causes of hypokalemic periodic paralysis (HPP) in EDs in Asia. Their neuromuscular presentations are almost indistinguishable. We conducted this study to identify clinical clues that can help EPs distinguish between TPP and SPP. Thirty-four patients presenting to the ED with HPP were enrolled during a 3-year period. They did not have known hyperthyroidism before the attack and no family history of paralysis. They all had low K+ excretion rates. Vital signs and blood biochemistry, including acid-base and electrolytes, were measured. TPP was subsequently established by thyroid function tests. Twenty patients had TPP and 14 patients had SPP. There was no significant difference in age and sex distribution between them. Systolic (SBP) but not diastolic blood pressure (SBP 146 ± 4 vs 128 ± 4 mm Hg, P <0.001) and heart rate (106 ± 3 vs 73 ± 3 beats/min, P <0.001) were significantly higher in those experiencing TPP than SPP. Among the biochemical factors, only plasma phosphate concentration (2.2 ± 0.2 vs 3.2 ± 0.2 mg/dL, P <0.001) was significantly lower in those experiencing TPP than SPP. Systolic hypertension, tachycardia, and hypophosphatemia are clinical clues favoring the diagnosis of TPP.",
keywords = "Beta-blockers, Blood pressure, Heart rate, Hyperthyroidism, Hypokalemia, Hypophosphatemia, Paralysis",
author = "Lin, {Yuh Feng} and Wu, {Chia Chao} and Dee Pei and Chu, {Shi Jye} and Lin, {Shih Hua}",
year = "2003",
month = "7",
doi = "10.1016/S0735-6757(03)00037-8",
language = "English",
volume = "21",
pages = "339--342",
journal = "American Journal of Emergency Medicine",
issn = "0735-6757",
publisher = "W.B. Saunders",
number = "4",

}

TY - JOUR

T1 - Diagnosing thyrotoxic periodic paralysis in the ED

AU - Lin, Yuh Feng

AU - Wu, Chia Chao

AU - Pei, Dee

AU - Chu, Shi Jye

AU - Lin, Shih Hua

PY - 2003/7

Y1 - 2003/7

N2 - Thyrotoxic periodic paralysis (TPP) and sporadic periodic paralysis (SPP) are the most common causes of hypokalemic periodic paralysis (HPP) in EDs in Asia. Their neuromuscular presentations are almost indistinguishable. We conducted this study to identify clinical clues that can help EPs distinguish between TPP and SPP. Thirty-four patients presenting to the ED with HPP were enrolled during a 3-year period. They did not have known hyperthyroidism before the attack and no family history of paralysis. They all had low K+ excretion rates. Vital signs and blood biochemistry, including acid-base and electrolytes, were measured. TPP was subsequently established by thyroid function tests. Twenty patients had TPP and 14 patients had SPP. There was no significant difference in age and sex distribution between them. Systolic (SBP) but not diastolic blood pressure (SBP 146 ± 4 vs 128 ± 4 mm Hg, P <0.001) and heart rate (106 ± 3 vs 73 ± 3 beats/min, P <0.001) were significantly higher in those experiencing TPP than SPP. Among the biochemical factors, only plasma phosphate concentration (2.2 ± 0.2 vs 3.2 ± 0.2 mg/dL, P <0.001) was significantly lower in those experiencing TPP than SPP. Systolic hypertension, tachycardia, and hypophosphatemia are clinical clues favoring the diagnosis of TPP.

AB - Thyrotoxic periodic paralysis (TPP) and sporadic periodic paralysis (SPP) are the most common causes of hypokalemic periodic paralysis (HPP) in EDs in Asia. Their neuromuscular presentations are almost indistinguishable. We conducted this study to identify clinical clues that can help EPs distinguish between TPP and SPP. Thirty-four patients presenting to the ED with HPP were enrolled during a 3-year period. They did not have known hyperthyroidism before the attack and no family history of paralysis. They all had low K+ excretion rates. Vital signs and blood biochemistry, including acid-base and electrolytes, were measured. TPP was subsequently established by thyroid function tests. Twenty patients had TPP and 14 patients had SPP. There was no significant difference in age and sex distribution between them. Systolic (SBP) but not diastolic blood pressure (SBP 146 ± 4 vs 128 ± 4 mm Hg, P <0.001) and heart rate (106 ± 3 vs 73 ± 3 beats/min, P <0.001) were significantly higher in those experiencing TPP than SPP. Among the biochemical factors, only plasma phosphate concentration (2.2 ± 0.2 vs 3.2 ± 0.2 mg/dL, P <0.001) was significantly lower in those experiencing TPP than SPP. Systolic hypertension, tachycardia, and hypophosphatemia are clinical clues favoring the diagnosis of TPP.

KW - Beta-blockers

KW - Blood pressure

KW - Heart rate

KW - Hyperthyroidism

KW - Hypokalemia

KW - Hypophosphatemia

KW - Paralysis

UR - http://www.scopus.com/inward/record.url?scp=0042574195&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0042574195&partnerID=8YFLogxK

U2 - 10.1016/S0735-6757(03)00037-8

DO - 10.1016/S0735-6757(03)00037-8

M3 - Article

C2 - 12898495

AN - SCOPUS:0042574195

VL - 21

SP - 339

EP - 342

JO - American Journal of Emergency Medicine

JF - American Journal of Emergency Medicine

SN - 0735-6757

IS - 4

ER -